Physician profile
Daniel C Desimone
NPI 1447246822
$1,053.56
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.36 · 2020: $211 · 2021: $382 · 2022: $406.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $138.10 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $106.16 | 2020-2022 | |
| Lilly USA, LLC | $104.64 | 2021-2022 | |
| Amarin Pharma, INC. | $76.83 | 2020-2022 | |
| Abbvie INC. | $76.27 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.48 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $67.62 | 2020 | |
| Pfizer INC. | $65.80 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $55.05 | 2022 | |
| Eisai INC. | $37.88 | 2020 | |
| Sanofi-Aventis U.S. LLC | $37.18 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.89 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $30.47 | 2022 | |
| Glaxosmithkline, LLC. | $30.37 | 2022 | |
| Medtronic, INC. | $20.08 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.17 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $18.86 | 2021 | |
| Amgen INC. | $18.75 | 2022 | |
| Vivus LLC | $18.50 | 2020 | |
| Allergan, INC. | $16.51 | 2020 | |
| Abbott Laboratories | $13.95 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Desimone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.